A webinar with IAPMD to discover how brain science could change PMDD outcomes + Q&A with Emilė Radytė, CEO & Founder of Samphire Neuroscience.
Summary
This webinar will explore new research into non-invasive brain stimulation for Premenstrual Dysphoric Disorder (PMDD). It will include a review of the recent study “Validation of a Non-Invasive Brain Stimulation Device (Nettle™) to Manage Symptoms of PMDD” and discuss what it could mean for future treatment options.
Following the review, participants attending live have the opportunity to take part in a Q&A with Emilé Radyte, PhD, CEO and Founder of Samphire Neuroscience, and inventor of the Nettle™ device. Those who view the recording post-webinar will have access to both the discussion and Q&A portion of the webinar.
